Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes [Switch da clopidogrel a prasugrel per migliorare il trattamento precocemente invasivo delle sindromi coronariche acute].

Trial Profile

Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes [Switch da clopidogrel a prasugrel per migliorare il trattamento precocemente invasivo delle sindromi coronariche acute].

Recruiting
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes; Coronary artery disease
  • Focus Pharmacodynamics
  • Acronyms SWITCH-OVER
  • Most Recent Events

    • 24 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top